Sökning: WFRF:(Trichopoulou Antonia) > Coffee and tea cons...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 05924naa a22010093a 4500 | |
001 | 19660107 | |
003 | SE-LIBR | |
005 | 20160906170230.0 | |
007 | cr|||||||||||| | |
008 | 160906s2015 sw |||| o |||| ||eng c | |
024 | 7 | a http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-1022452 uri |
024 | 7 | a urn:nbn:se:umu:diva-1022452 urn |
024 | 7 | a 10.1186/s13058-015-0521-32 doi |
040 | a S | |
041 | 0 | a eng |
042 | 9 EPLK | |
100 | 1 | a Bhoo-Pathy, Nirmala4 aut |
245 | 1 0 | a Coffee and tea consumption and risk of pre- and postmenopausal breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort studyh [Elektronisk resurs] |
260 | c 2015 | |
500 | a Published | |
506 | 0 | a gratis |
520 | a Introduction: Specific coffee subtypes and tea may impact risk of pre- and post-menopausal breast cancer differently. We investigated the association between coffee (total, caffeinated, decaffeinated) and tea intake and risk of breast cancer. Methods: A total of 335,060 women participating in the European Prospective Investigation into Nutrition and Cancer (EPIC) Study, completed a dietary questionnaire from 1992 to 2000, and were followed-up until 2010 for incidence of breast cancer. Hazard ratios (HR) of breast cancer by country-specific, as well as cohort-wide categories of beverage intake were estimated. Results: During an average follow-up of 11 years, 1064 premenopausal, and 9134 postmenopausal breast cancers were diagnosed. Caffeinated coffee intake was associated with lower risk of postmenopausal breast cancer: adjusted HR = 0.90, 95% confidence interval (CI): 0.82 to 0.98, for high versus low consumption; P-trend = 0.029. While there was no significant effect modification by hormone receptor status (P = 0.711), linear trend for lower risk of breast cancer with increasing caffeinated coffee intake was clearest for estrogen and progesterone receptor negative (ER-PR-), postmenopausal breast cancer (P = 0.008). For every 100 ml increase in caffeinated coffee intake, the risk of ER-PR- breast cancer was lower by 4% (adjusted HR: 0.96, 95% CI: 0.93 to 1.00). Non-consumers of decaffeinated coffee had lower risk of postmenopausal breast cancer (adjusted HR = 0.89; 95% CI: 0.80 to 0.99) compared to low consumers, without evidence of dose-response relationship (P-trend = 0.128). Exclusive decaffeinated coffee consumption was not related to postmenopausal breast cancer risk, compared to any decaffeinated-low caffeinated intake (adjusted HR = 0.97; 95% CI: 0.82 to 1.14), or to no intake of any coffee (HR: 0.96; 95%: 0.82 to 1.14). Caffeinated and decaffeinated coffee were not associated with premenopausal breast cancer. Tea intake was neither associated with pre- nor post-menopausal breast cancer. Conclusions: Higher caffeinated coffee intake may be associated with lower risk of postmenopausal breast cancer. Decaffeinated coffee intake does not seem to be associated with breast cancer. | |
650 | 7 | a Medical and Health Sciences2 hsv |
650 | 7 | a Clinical Medicine2 hsv |
650 | 7 | a Cancer and Oncology2 hsv |
650 | 7 | a Medicin och hälsovetenskap2 hsv |
650 | 7 | a Klinisk medicin2 hsv |
650 | 7 | a Cancer och onkologi2 hsv |
700 | 1 | a Peeters, Petra H. M.4 aut |
700 | 1 | a Uiterwaal, Cuno S. P. M.4 aut |
700 | 1 | a Bueno-de-Mesquita, H. Bas4 aut |
700 | 1 | a Bulgiba, Awang M.4 aut |
700 | 1 | a Bech, Bodil Hammer4 aut |
700 | 1 | a Overvad, Kim4 aut |
700 | 1 | a Tjønneland, Anne4 aut |
700 | 1 | a Olsen, Anja4 aut |
700 | 1 | a Clavel-Chapelon, Francoise4 aut |
700 | 1 | a Fagherazzi, Guy4 aut |
700 | 1 | a Perquier, Florence4 aut |
700 | 1 | a Teucher, Birgit4 aut |
700 | 1 | a Kaaks, Rudolf4 aut |
700 | 1 | a Schuetze, Madlen4 aut |
700 | 1 | a Boeing, Heiner4 aut |
700 | 1 | a Lagiou, Pagona4 aut |
700 | 1 | a Orfanos, Philippos4 aut |
700 | 1 | a Trichopoulou, Antonia4 aut |
700 | 1 | a Agnoli, Claudia4 aut |
700 | 1 | a Mattiello, Amalia4 aut |
700 | 1 | a Palli, Domenico4 aut |
700 | 1 | a Tumino, Rosario4 aut |
700 | 1 | a Sacerdote, Carlotta4 aut |
700 | 1 | a van Duijnhoven, Franzel J. B.4 aut |
700 | 1 | a Braaten, Tonje4 aut |
700 | 1 | a Lund, Eiliv4 aut |
700 | 1 | a Skeie, Guri4 aut |
700 | 1 | a Redondo, Maria-Luisa4 aut |
700 | 1 | a Buckland, Genevieve4 aut |
700 | 1 | a Sanchez Perez, Maria Jose4 aut |
700 | 1 | a Chirlaque, Maria-Dolores4 aut |
700 | 1 | a Ardanaz, Eva4 aut |
700 | 1 | a Amiano, Pilar4 aut |
700 | 1 | a Wirfalt, Elisabet4 aut |
700 | 1 | a Wallstrom, Peter4 aut |
700 | 1 | a Johansson, Ingegerd4 aut |
700 | 1 | a Nilsson, Lena Maria4 aut |
700 | 1 | a Khaw, Kay-Tee4 aut |
700 | 1 | a Wareham, Nick4 aut |
700 | 1 | a Allen, Naomi E.4 aut |
700 | 1 | a Key, Timothy J.4 aut |
700 | 1 | a Rinaldi, Sabina4 aut |
700 | 1 | a Romieu, Isabelle4 aut |
700 | 1 | a Gallo, Valentina4 aut |
700 | 1 | a Riboli, Elio4 aut |
700 | 1 | a van Gils, Carla H.4 aut |
710 | 1 | a Umeå universitetb Medicinska fakulteten4 pbl0 268483 |
710 | 1 | a Umeå universitetb Medicinska fakulteten4 pbl0 268483 |
772 | 1 8 | i channel recordw 18813935 |
773 | 0 | i Värdpublikationt Breast Cancer Researchg 17x 1465-542X |
856 | 4 0 | u http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-102245 |
856 | 4 0 | u http://dx.doi.org/10.1186/s13058-015-0521-3 |
856 | 4 0 | u http://umu.diva-portal.org/smash/get/diva2:808310/FULLTEXT01 |
910 | 2 s | 6 710,710a Umeå universitet.b Medicinsk-odontologiska fakultetenu Umeå universitet.b Medicinska fakulteten |
910 | 2 s | 6 710,710a Medicinska fakulteten vid Umeå universitetu Umeå universitet.b Medicinska fakulteten |
841 | 5 APISa x ab 160906||0000|||||001||||||000000e 1 | |
024 | 7 | 5 APISa urn:nbn:se:umu:diva-1022452 urn |
852 | 5 APISb APIS | |
856 | 4 0 | 5 APISu http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-102245 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.